Format

Send to

Choose Destination
Head Neck. 2013 Jun;35(6):788-93. doi: 10.1002/hed.23032. Epub 2012 May 11.

Follow-up of parotid pleomorphic adenomas treated by extracapsular dissection.

Author information

1
Department of Otorhinolaryngology, Head and Neck Surgery, University of Erlangen-Nuremberg, Erlangen, Germany. heinrich.iro@uk-erlangen.de

Abstract

BACKGROUND:

This study was carried out to evaluate tumor recurrence following extracapsular dissection of pleomorphic adenomas of the parotid gland.

METHODS:

We conducted a retrospective evaluation and clinical follow-up of the patients who underwent extracapsular dissection of a pleomorphic adenoma as primary surgery in the otolaryngologic department of the Erlangen University Clinics during the period from 2000 to 2005.

RESULTS:

In all, 601 surgical interventions on benign parotid tumors were carried out from 2000 to 2005, 219 of which were primary operations for removal of a pleomorphic adenoma. In 76 patients (34.7%), extracapsular dissection of a primary pleomorphic adenoma was carried out. Tumor recurrence has not been observed in any of these patients to date after an average monitoring period of 7.38 years (range, 5.05-10.52 years).

CONCLUSIONS:

Extracapsular dissection is a conservative and safe surgical procedure for extirpation of pleomorphic adenomas that should be firmly established in the repertoire of parotid gland surgery.

PMID:
22581729
DOI:
10.1002/hed.23032
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center